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C. elegans EGL-9 and Mammalian Homologs Define
a Family of Dioxygenases that Regulate HIF
by Prolyl Hydroxylation
playing a central role in both local and systemic re-
sponses to hypoxia (Semenza, 2000b; Wenger, 2000).
In keeping with this, HIF is activated in a broad array of
ischemic/hypoxic and neoplastic diseases (Semenza,
2000a). The central role of HIF in developmental, physio-
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mechanism, other processes provide additional points
of regulation in a multistep activation process (Semenza,
2000b; Wenger, 2000). Activation of the HIF system bySummary
iron chelators and cobaltous ions as well as hypoxia
has led to the proposal of a ferroprotein oxygen sensor,HIF is a transcriptional complex that plays a central
role in mammalian oxygen homeostasis. Recent stud- though the nature of such a protein(s) and mode(s) of
interaction with HIF have remained largely unclear (Se-ies have defined posttranslational modification by pro-
lyl hydroxylation as a key regulatory event that targets menza, 1999; Zhu and Bunn, 2001).
Recently, new insights into the mechanism of regula-HIF- subunits for proteasomal destruction via the von
Hippel-Lindau ubiquitylation complex. Here, we define tion by availability of oxygen have been gained from
studies of the role of the von Hippel-Lindau tumor sup-a conserved HIF-VHL-prolyl hydroxylase pathway in
C. elegans, and use a genetic approach to identify pressor protein (VHL) in proteolytic degradation. Both
HIF-1 and HIF-2 contain an extensive transferableEGL-9 as a dioxygenase that regulates HIF by prolyl
hydroxylation. In mammalian cells, we show that the oxygen-dependent degradation domain (ODDD) (Huang
et al., 1998; O’Rourke et al., 1999). VHL interacts withHIF-prolyl hydroxylases are represented by a series of
isoforms bearing a conserved 2-histidine-1-carboxyl- subsequences within the HIF- ODDDs, acting as the
recognition component of a multiprotein ubiquitin E3ate iron coordination motif at the catalytic site. Direct
modulation of recombinant enzyme activity by graded ligase complex (Cockman et al., 2000; Kamura et al.,
hypoxia, iron chelation, and cobaltous ions mirrors 2000; Maxwell et al., 1999; Ohh et al., 2000; Tanimoto
the characteristics of HIF induction in vivo, fulfilling et al., 2000). Further analysis of this interaction has
requirements for these enzymes being oxygen sensors shown that the recognition of HIF- subunits by VHL is
that regulate HIF. regulated through enzymatic hydroxylation of specific
prolyl residues within the HIF- ODDD (Ivan et al., 2001;
Introduction Jaakkola et al., 2001; Masson et al., 2001). Though the
enzyme was not identified in these studies, indirect anal-
Oxygen homeostasis presents a fundamental physio- ysis of substrate requirements and inhibition by 2-oxo-
logical challenge that requires the coordinate regulation glutarate analogs suggested that the HIF-prolyl hydrox-
of extensive arrays of genes. In mammalian cells, the ylase(s) (HIF-PHs) are likely to belong to the extended
transcriptional complex hypoxia inducible factor (HIF) superfamily of 2-oxoglutarate-dependent-oxygenases
has emerged as a key regulator of these processes, (for review, see Hegg and Que, 1997; Schofield and
Zhang, 1999). Since enzymes of this type have an abso-
lute requirement for dioxygen as cosubstrate, these pre-5 Correspondence: peter.ratcliffe@imm.ox.ac.uk
6 These authors contributed equally to this work. dictions provided a direct link between the regulation
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of HIF and molecular oxygen, and suggested a role for Critical Function of a VHL Homolog
in the Regulation of CeHIF-1the postulated enzyme(s) as oxygen sensors.
We next compared CeHIF-1 expression in wild-type andTo pursue these potential insights into oxygen sensing
a series of mutant worms that were selected becauseand proteolytic targeting by prolyl hydroxylation, we
of potential relevance to previously proposed modelsaimed to identify and characterize the relevant en-
for oxygen sensing and signal transduction in the mam-zyme(s) using a combination of evolutionary, genetic,
malian HIF system (for review, see Semenza, 1999; Zhuand biochemical methods. In this work, we demonstrate
and Bunn, 2001). These included mutants in the PTEN/the existence of an HIF- homolog (HIF-1) in C. elegans
insulin receptor/PI-3-kinase pathway (daf-18, daf-2,that is identical to that identified in recently published
age-1), a mutant in a putative homolog of VHL (vhl-1),independent work describing mutant worms lacking this
mutants affecting mitochondrial proteins (mev-1, clk-1,gene (Jiang et al., 2001). We further show that regulation
gas-1), a mutant that affects cytosolic catalase activityof this homolog is dependent on a conserved mecha-
ctl-1, and others selected for resistance or sensitivitynism of targeting by a VHL homolog following prolyl
to oxidant stresses, but where the mutant gene is nothydroxylation. Analysis of mutant worms identified the
yet characterized (mev-2, mev-3). Representative immu-egl-9 gene as critical for this process, and we show that
noblots are shown in Figure 1B. With the exception ofthe product is a 2-oxoglutarate-dependent dioxygenase
vhl-1 all mutant worms showed preserved regulationthat regulates HIF-1 through prolyl hydroxylation at a
of CeHIF-1 protein levels. In contrast, the vhl-1 wormsconserved core LXXLAP motif, thus defining a novel
showed high levels of CeHIF-1 in normoxia that wereclass of prolyl hydroxylase. In mammalian cells, we show
unregulated by oxygen. These results confirmed the pro-that this family is represented by a series of isoforms
posed homology for vhl-1 (Woodward et al., 2000), andthat act differentially on prolyl hydroxylation sites within
indicated a conserved role for C. elegans VHL (CeVHL-1)HIF-, and that recombinant enzyme activity is directly
in the response to hypoxia.modulated by oxygen tension, providing the basis for
an oxygen sensing function.
Interaction of CeHIF-1 with CeVHL-1 Is Regulated
by Prolyl HydroxylationResults
To address the mechanism of regulation of CeHIF-1 by
CeVHL-1, we next tested for interaction between the twoIdentification and Characterization of a HIF-
proteins. 35S-methionine-labeled, haemagglutinin (HA)-Homolog in C. elegans
tagged CeVHL-1 (HA.CeVHL-1) and CeHIF-1 were pro-We first sought homologs to HIF- subunits in the C.
duced separately in vitro in coupled transcription trans-elegans EST database using a tBLASTn enquiry with
lation reactions (IVTT) in reticulocyte lysate. IVTTs werethe human sequence. The EST contig we identified is
then mixed and assayed for interaction by anti-HA im-identical to an open reading frame (F38A6.3) that was
munoprecipitation. When produced in this way, the pro-predicted following determination of the C. elegans ge-
teins did not interact. However, when recombinantnome sequence, except for a 104 amino acid amino-
CeHIF-1 was preincubated with worm extract, interac-terminal extension in the latter. No further ESTs or PCR
tion was observed (Figure 2A).
products corresponding to the extension could be iden-
To study this further, N-terminal truncations of
tified and RACE-PCR products contained a putative
CeHIF-1 linked to a Gal4 DNA binding domain were
trans spliced leader sequence. These findings predict constructed. The Gal/CeHIF-1 fusion proteins were ex-
that F38A6.3 encodes a 719 amino acid polypeptide that pressed in reticulocyte lysates, preincubated with worm
lacks the proposed amino terminal extension (Supple- extracts, and then tested for interaction with HA.CeVHL-1.
mental Figure S1, available online at http://www.cell. These experiments demonstrated that while N-terminal
com/cgi/content/full/107/1/43/DC1) and was named truncations up to and including Gal/CeHIF-1 (590-719)
HIF-1. To avoid ambiguity, we have used the species were captured efficiently by HA.CeVHL-1, Gal/CeHIF-
descriptors Hs and Ce as prefixes to distinguish relevant 1(641-719) was not, implicating CeHIF-1 amino acids
human and C. elegans proteins and genes throughout 590–641 in the interaction (Figure 2B). Inspection of this
the remainder of the manuscript. region revealed homology to VHL binding domains in
To characterize the regulation of C. elegans HIF-1 HsHIF-1 that contain sites of prolyl hydroxylation (Ivan
(CeHIF-1), we raised antisera to a recombinant polypep- et al., 2001; Jaakkola et al., 2001; Masson et al., 2001)
tide, and immunoblotted worm extracts prepared from (Figure 2C). We therefore mutated the homologous prolyl
worms exposed to hypoxia, or the cell penetrating iron residue in CeHIF-1 (P621→G) and found that this mu-
chelator 2, 2 dipyridyl. Immunoblotting showed striking tation ablated interaction with HA.CeVHL-1 (Figure 2D).
induction of CeHIF-1 by both stimuli. Induction by hy- This suggested that the mechanism regulating the
poxia was maximal at the lowest tested concentrations CeHIF-1/CeVHL-1 interaction through enzymatic prolyl
of 0.5% and 0.1% oxygen. In 0.1% oxygen, CeHIF-1 hydroxylation might also be conserved in C. elegans.
protein level was strongly induced within 4 hr, and sus- To test this, N-oxalyl-2S-alanine, a 2-oxoglutarate ana-
tained over 24 hr, but disappeared within minutes follow- log that inhibits this class of enzyme, was added to the
ing reoxygenation (Figure 1A). In contrast, CeHIF-1 en- worm extract during preincubation with HIF-1. Inhibition
coding mRNA levels were unchanged by hypoxia (data was observed that was competed by excess 2-oxoglu-
not shown). Thus, these experiments confirmed upregu- tarate (Figure 2E). To test whether hydroxylation of the
lation of CeHIF-1 by hypoxia, and suggested a mode of critical P621 residue in CeHIF-1 could indeed promote
regulation at the protein level similar to that described binding to CeVHL-1, we synthesized N-terminal biotinyl-
ated peptides corresponding to residues 607–634 offor mammalian HIF- subunits.
HIF-Prolyl Hydroxylases
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Figure 1. Regulation of CeHIF-1 in Wild-type
and Mutant Worms
(A) Representative immunoblots showing in-
duction of HIF-1 protein in worms exposed
to the indicated oxygen levels for 16 hr or
normoxic growth without () or with iron che-
lator 22 dipyridyl, 200 M (DIP) for the indi-
cated times. The time course of HIF accumu-
lation on exposure to 0.1% O2 is shown, as
is the rapid reduction on reoxygenation with
air (ReOx) following 16 hr of 0.1% hypoxia (H).
(B) Immunoblots of HIF-1 protein in extracts
prepared from wild-type (wt) or mutant
worms. N, normoxia; H, hypoxia; for a period
of 16 hr unless specified otherwise.
CeHIF-1 that contained either a proline (B28Pro) or a mal (egl) phenotype (Trent et al., 1983) (Figure 4). Se-
quence analyses coupled with secondary structure pre-(2S,4R)-trans-hydroxyproline residue (B28Hyp) at posi-
tion 621. B28Hyp, but not B28Pro blocked capture of dictions in the light of crystallographic data (Zhang et
al., 2000) predicted that these genes would encode apretreated CeHIF-1 by HA.CeVHL-1 when added to the
interaction mix (Figure 2F). Futhermore, B28Hyp, but not family of enzymes conserved in C. elegans and mam-
B28Pro captured immunodetectable native CeVHL-1 mals. The predictions suggested that the enzymes
from extracts of wild-type, but not vhl-1 mutant worms would contain not only the jelly roll motif, but also con-
(Figure 2G). Finally, to test the importance of prolyl hy- served iron and 2-oxoglutarate binding residues in the
droxylation in regulating CeHIF-1 in vivo, we exposed same relationship that they occur in crystallographically
worms to the cell penetrating prolyl hydroxylase inhibi- characterized members of the family (e.g., the HXD…H
tor, dimethyloxalylglycine (Jaakkola et al., 2001). This iron binding motif on the second and seventh strands
strongly induced CeHIF-1 in normoxic worms (Figure of the jelly roll motif).
3A). These results demonstrated that conservation of Mutant worms containing defective egl-9 alleles were
the HIF/VHL system in C. elegans extends to the mode analyzed for regulation of HIF-1. Three strains bearing
of regulation by prolyl hydroxylation. inactivating mutant alleles of egl-9, (sa307, sa330, and
n571) (Darby et al., 1999; Trent et al., 1983) all showed
striking upregulation of CeHIF-1 in normoxia and lossThe C. elegans egl-9 Gene Product
of induction by hypoxia (Figure 3C). Moreover, a temper-Is a Prototype HIF-PH
ature-sensitive egl-9 mutant, n586, showed enhancedThe best characterized prolyl hydroxylases are the pro-
normoxic CeHIF-1 levels at the nonpermissive tempera-collagen modifying enzymes (Kivirikko and Myllyharju,
ture (Figure 3D). To determine the effect of EGL-9 on the1998). However, worms containing inactivating muta-
CeHIF-1 transcriptional response, we measured mRNAtions in each of two isoforms of the catalytic -subunits,
levels of a range of hypoxia inducible transcripts anddpy-18 (also termed phy-1) and phy-2, showed normal
found striking upregulation in egl-9 worms. Figure 3ECeHIF-1 regulation, consistent with HIF-PH being dis-
shows data for a strongly inducible mRNA of unknowntinct from the collagen modifying enzymes (Figure 3B).
function (F22B5.4), that we have identified in gene arrayBased on the prediction that the HIF-PHs would belong
screens of vhl-1 worms (A.E. and S. Kim, unpublishedto the 2-oxoglutarate-dependent oxygenase superfam-
results). These findings demonstrated a critical functionily that possess a common -barrel jelly roll motif, we
for EGL-9 in the regulation of CeHIF-1 and strongly sug-searched C. elegans and mammalian databases for ad-
gested that EGL-9 might function as a HIF-PH that tar-ditional candidates that were well conserved between
gets CeHIF-1 to CeVHL-1.these species and conformed to the 2-oxoglutarate-
To test this, we produced recombinant EGL-9 anddependent oxygenase archetype model. Of particular
assessed its ability to catalyze the posttranslationalinterest was a family of genes related to the C. elegans
modification of CeHIF-1. CeHIF-1 was captured effi-gene egl-9, a gene of previously unknown function that
was first identified on the basis of an egg-laying abnor- ciently by HA.CeVHL-1 after incubation with EGL-9 pro-
Cell
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Figure 2. Interaction between CeHIF-1 and
CeVHL-1 Is Regulated by Prolyl Hydroxyl-
ation
(A) Interaction between 35S-labeled
HA.CeVHL-1 and CeHIF-1 assayed by coim-
munoprecipitation using anti-HA. Pretreat-
ment of CeHIF-1 with worm extract promotes
the interaction (compare lanes 3 and 4).
(B) Interaction between HA.CeVHL-1 and ex-
tract-treated CeHIF-1 or Gal/CeHIF-1 fusions
(G) containing the indicated CeHIF-1 se-
quences. Upper panel, 35S-labeled proteins
captured by anti-HA immunoprecipitation;
lower panel, inputs. Despite equivalent input,
GalCeHIF-1(641-719) is not captured. Note,
the additional GalCeHIF-1 species arise from
an aberrant initiation site within the Gal se-
quences.
(C) Alignment of C. elegans CeHIF-1 se-
quences with VHL binding sites in mammalian
HIF-1. Core LXXLAP motif is overlined.
(D) Mutation at CeHIF-1 prolyl residue 621
(P621G) ablates the interaction between ex-
tract-treated CeHIF-1 and HA.CeVHL-1.
(E) Effect of the 2-oxoglutarate analog
N-oxalyl-2S-alanine (1 mM) on the ability of
worm extract to promote interaction between
CeHIF-1 and HA.CeVHL-1. Inhibition is antag-
onized by excess (5 mM) 2-oxoglutarate
(compare lanes 3 and 4).
(F) Blocking of interaction between extract-
treated CeHIF-1 and HA.CeVHL-1 by syn-
thetic peptides corresponding to amino acids
607–634 of CeHIF-1. Peptide containing hy-
droxyproline at position 621 (B28Hyp) blocked
the interaction effectively, whereas peptide
containing proline at this position (B28Pro)
did not.
(G) CeVHL-1 immunoblot of proteins cap-
tured from extract of wild-type (WT) or vhl-1
mutant worms using streptavidin pull down
of biotinylated peptides. Detection by rabbit
anti-serum raised against CeVHL-1. B28Hyp,
but not B28Pro captured native CeVHL-1.
grammed reticulocyte or wheat germ lysates, but not N-terminal Gal fusion proteins in either insect cells or E.
coli and purified by anti-Gal immunoprecipitation. Theseunprogrammed lysate (Figure 5A). In contrast, IVTTs ex-
pressing recombinant C. elegans PHY-1 (DPY-18), PHY-2, substrates were incubated with lysates of insect cells
expressing full-length EGL-9 or purified MBP/N.EGL-9,and the gene product of the predicted ORF T20B3.7,
which also has significant homology to prolyl hydroxy- and tested for ability to capture CeVHL-1. Both forms
of recombinant EGL-9 efficiently promoted modificationlases, had no activity in these assays (data not shown).
To test whether EGL-9 could act directly on CeHIF-1, of CeHIF-1 as indicated by HA.CeVHL-1 capture. More-
over, analysis of this activity demonstrated 2-oxoglutar-further preparations were made by baculoviral expres-
sion in insect cells and by expression as maltose binding ate, iron, and oxygen dependence, and direct inhibition
by cobaltous ions (Figures 5B and 5C).protein (MBP) fusion proteins in E. coli. Since full-length
MBP/EGL-9 protein was insoluble in E. coli, we prepared To demonstrate that activity in the HA.CeVHL-1 cap-
ture assays corresponded to hydroxylation of the criticalan N-terminal truncation containing residues 359–723
(MBP/N.EGL-9) that preserved the predicted catalytic CeHIF-1 residue P621, we assayed modified CeHIF-1
polypeptides for 4-hydroxyproline content by HPLC. Todomain and had CeHIF-1 modifying activity when ex-
pressed as an IVTT. CeHIF-1 substrates were made as provide larger quantities of protein for analysis, we co-
HIF-Prolyl Hydroxylases
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Figure 3. Prolyl Hydroxylation and the egl-9
Gene Have a Critical Role in the Regulation
of CeHIF-1
(A–D) Representative immunoblots of CeHIF-1
levels in worm extracts.
(A) Induction of CeHIF-1 in C. elegans by di-
methyloxalylglycine (1 mM, 6 hr).
(B) CeHIF-1 levels in collagen-type prolyl hy-
droxylase mutant worms dpy-18 and phy-2.
(C) CeHIF-1 levels in wild-type and egl-9 mu-
tants. Constitutive upregulation of CeHIF-1 is
observed with all egl-9 mutant alleles. Note
that the lower total level of CeHIF-1 in the
strain containing the sa330 allele was a con-
sistent finding, possibly indicating the exis-
tence of a modifying genetic influence on
overall CeHIF-1 expression.
(D) CeHIF-1 protein levels in normoxic wild-
type (WT) worms, and a temperature-sensi-
tive egl-9 mutant containing allele n586.
Upregulation of CeHIF-1 is increased at the
nonpermissive temperature (25C) at which
the egg laying abnormal phenotype is ob-
served.
(E) Representative RNase protection assays
of mRNA for the hypoxia-inducible transcript
F22B5.4 in wild-type and egl-9 mutant (sa307)
worms.
transformed E. coli with wild-type or a P621→G mutant the interaction between HsHIF- subunits and the
HsVHL E3 ligase complex, we first produced the proteinsHis6/Gal/CeHIF-1(590-719) fusion protein and either MBP/
N.EGL-9 or MBP. His6/Gal/CeHIF-1 substrates were by reticulocyte IVTT. Since unprogrammed lysate has
low-level HIF-PH activity (Jaakkola et al., 2001), weretrieved by nickel affinity chromatograghy and aliquots
assayed for ability to capture 35S-methionine labeled tested for enhanced ability of the programmed lysates
to promote the HsHIF-/HsVHL E3 interaction. After in-HA.CeVHL-1 using anti-Gal immunoprecipitation, or sub-
jected to acid hydrolysis and HPLC analysis for 4-hy- cubation with relevant enzyme, HsHIF- substrates
were mixed with extracts from 786-0/VHL cells that sta-droxyproline. In concordance with the HA.CeVHL-1 cap-
ture assay results, 4-hydroxyproline was produced in bly express HA-tagged HsVHL, and tested for interac-
tion by anti-HA immunoprecipitation. Figure 6A showswild-type, but not mutant His6/Gal/CeHIF-1 substrate
after exposure to enzyme (Figure 5D). These results results for wild-type and mutant HsHIF-1. With wild-
type HsHIF-1, striking activity was observed with ratdemonstrate the critical function of EGL-9 as a prolyl
hydroxylase that targets CeHIF-1 to CeVHL-1 in C. SM-20 and all three human gene products, but not a
mutant PHD1 bearing an H358A substitution at the pre-elegans.
dicted catalytic site, and not a different human 2-oxoglu-
tarate dependent oxygenase (phytanoyl coenzyme A hy-Identification of a Series of Mammalian
HIF-PH Isoforms droxylase [Mukherji et al., 2001]) that was tested as
a negative control. Similar results were obtained withSequence similarity between EGL-9 and a rat gene prod-
uct termed SM-20 has been noted previously, though HsHIF-2 (data not shown). Examination of HsHIF-1
mutants bearing missense substitutions at the criticalno functional connection was recognized (Wax et al.,
1994; Darby et al., 1999). Our sequence-structure search prolyl residues in the HsHIF-1 ODDD (Masson et al.,
2001) showed that enzymes were differentially efficientidentified a larger series of homologies and predicted
three related genes in each of the human and rodent at promoting interaction via the C-terminal (P564) and
N-terminal (P402) prolyl hydroxylation sites. Whereasgenomes that bore striking homology to egl-9, particu-
larly over the core putative catalytic domain. Figure 4 interaction through the C-terminal site was promoted
by all enzymes, HsVHL E3 capture was less efficientillustrates sequence alignment of EGL-9 (accession num-
ber AAD56365), rat SM-20 (accesion number AAA19321), when only the N-terminal site (P402) was intact, and
was only promoted by PHD1 and PHD2. No activity atand the predicted human proteins defined by accession
numbers XP_040482, AAG33965, and NP_071356, cor- all was observed with a double HsHIF-1mutant, P402A
P564G, that ablates both hydroxylation sites. In keepingresponding to Unigene clusters Hs.324277, Hs.6523,
and Hs.18878. We provisionally termed the human pro- with these results, all enzymes strongly promoted cap-
ture of HA.HsVHL by isolated HsHIF-1 sequences fromtein products “prolyl hydroxylase domain containing”
(PHD) 1, 2, and 3, respectively. Note that the gene we the C-terminal site using a Gal/HsHIF-1(549-582) fusion
protein substrate and anti-Gal immunoprecipitation.term PHD2 has previously been identified as a human
homolog of rat SM-20 (Dupuy et al., 2000), though our Further analysis demonstrated that this activity was
strongly inhibited by iron chelation, cobaltous ions, andalignment indicates that PHD3 has greater homology.
To test the role of these gene products in regulating the 2-oxoglutarate analog N-oxalylglycine (Figure 6B),
Cell
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Figure 4. Predicted Conformation and Sequence Alignments for EGL-9 and Mammalian Homologs
(A) Topography diagram of the conserved jelly roll core (strands 1–8) of 2-oxoglutarate-dependent oxygenases, showing the approximate
location of the conserved 2-histidine-1-carboxylate iron binding ligands, and 2-oxoglutarate binding basic residue (Arg-557), that were used
to identify candidate HIF-PHs. Numbering refers to the position of these residues in the prototype, EGL-9.
(B) Sequence alignments of the predicted jelly roll cores of the HIF-PHs. Residues (as defined by the sequence depositions indicated in the
text) are C. elegans EGL-9 (462-580); human PHD1 (272-386); human PHD2 (288-403); human PHD3 (111-225); and rat SM-20 (226-341). Also
shown is the crystallographically determined secondary structure of Streptomyces sp. prolyl-3-hydroxylase (P30H) (I.C.Clifton, K.Harlos, C.J.S.,
and coworkers, unpublished results) that was used to model the analysis (Barton, 1993). Identical residues in all six proteins are colored in
red, residues identical in five in black, and conserved residues in light gray. The eight strands of the jelly roll core are indicated in green. The
residues of the 2-histidine-1-aspartate motif are indicated by arrows, as is the arginine proposed to bind the 5-carboxylate of 2-oxoglutarate
(Mukherji et al., 2001).
though variation between enzymes was observed in the coli and assayed activity using either purified His-tagged
HsHIF-1 polypeptides containing the N-terminal (344-sensitivity to N-oxalylglycine and competition by excess
2-oxoglutarate. No capture of enzyme was observed in 503) or C-terminal (530-698) hydroxylation sites, or a
synthetic peptide consisting of the minimal HsHIF-1these immunoprecipitates, most probably reflecting the
transient nature of the enzyme/substrate interaction. C-terminal substrate (B19Pro, residues 556–574). These
experiments demonstrated activity by VHL captureTo confirm direct action on HsHIF- sequences, we
prepared purified PHD-1 as an MBP fusion protein in E. assays, HPLC/MS detection of the hydroxylated peptide
HIF-Prolyl Hydroxylases
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Figure 5. EGL-9 Regulates the Interaction of CeHIF-1 with CeVHL-1 by Prolyl Hydroxylation
(A) Modification of CeHIF-1 by EGL-9. 35S-labeled CeHIF-1 and HA.CeVHL-1 were prepared in reticulocyte lysate. The CeHIF-1 was incubated
with worm extract (lane 1), EGL-9 programmed reticulocyte (lane 3), or wheat germ (lane 5) lysate, or unprogrammed lysates (lanes 4 and 6),
then mixed with HA.CeVHL-1 and assayed for interaction by coimmunoprecipitation using anti-HA.
(B) Effect of hypoxia on activity of EGL-9. Purified GalCeHIF-1(289-719) substrate was incubated with EGL-9 baculovirus-infected, or uninfected
insect cell lysates, recaptured using anti-Gal beads, then assayed for ability to capture 35S-labeled HA.CeVHL. Upper panel, EGL-9 infected
but not uninfected lysate (Sf-9) modifies the GalCeHIF-1 substrate to promote capture of HA.CeVHL-1. Lower panel, reaction in anoxia
suppresses activity of EGL-9.
(C) Effect of iron (100 M), 2-oxoglutarate (2 mM), and cobalt (100 M) on activity of recombinant EGL-9. Purified GalCeHIF-1(590-719)
substrate was incubated with purified MBP/N.EGL9, and tested for ability to capture 35S-labeled HA.CeVHL. Activity is dependent on
2-oxoglutarate, enhanced by iron, and inhibited by cobalt. Right hand lane, mutant GalCeHIF-1 (P621G) substrate. Note, some nonspecific
HA.CeVHL capture is observed under these conditions (see also [D]).
(D) EGL-9 hydroxylates prolyl residue 621 in CeHIF-1. E. coli were cotransformed with a plasmid expressing either His6GalCeHIF-1(590-719),
or a mutant (P621G) derivative, and plasmids expressing MBP/N.EGL9 or MBP alone. Retrieved His6CeGalHIF-1 was subject to HPLC analysis
for 4-hydroxyproline (upper panel) or tested for ability to capture 35S-labeled HA.CeVHL (lower panel).
product, or derivatized 4-hydroxyproline, and by 2-oxo- in HeLa cells and that in this cell line, transcripts for
PHD2 and PHD3, but not PHD1 are induced by hypoxiaglutarate decarboxylation assays (Figure 6C, and data
not shown). (Figure 7A). In keeping with this, semiquantitative analy-
sis of lysates prepared from HeLa cells that had beenTo verify expression of all three isoforms, we per-
formed RNase protection analysis using riboprobes grown in normoxia or exposed to hypoxia for 16 hr, then
assayed for HIF-PH activity in vitro using the HsVHLspecific for each transcript. Since the rate of HsHIF deg-
radation in normoxia is enhanced by prior exposure of capture assay, demonstrated induction of total HIF-PH
activity that was blocked by actinomycin D (Figure 7B).cells to a period of hypoxia (Berra et al., 2001), it has
been predicted that HIF-PH would itself be induced by Finally, we used HsVHL capture assays to measure the
activity in vitro of recombinant PHD-1 on an HsHIF-1the transcriptional response to hypoxia. RNase protec-
tion showed that all three HIF-PH mRNAs are expressed 549–582 substrate at graded levels of hypoxia in a con-
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Figure 6. Interaction between HsHIF- and HsVHL Is Regulated by a Series of HIF-PH Isoforms
(A) Recombinant HIF-PH isoforms modify HsHIF-1 in a site-specific manner. Representative experiment showing capture of HsHIF-1 by
HsVHL E3. 35S-labeled, full-length wild-type or mutant HsHIF-1 substrates were produced by IVTT, and incubated with 35S-labeled, full-length
recombinant enzymes. Treated HsHIF-1 was interacted with extracts from 786-0/VHL cells that stably express HA.HsVHL, and assayed for
interaction by anti-HA immunoprecipitation. Upper panels; captured wild-type and mutant HsHIF-1 substrates. Lowest panel; enzyme inputs.
PAHX, phytanoyl coenzyme A hydroxylase. Note that under the conditions of assay, enzyme was not immunoprepicated. Input HsHIF-1
levels were equivalent (not shown).
(B) Activity of PHD-1, 2, and 3 assayed by HsVHL capture using HsHIF-1 residues 549–582 as substrate. Representative capture assays
showing the effect of the 2-oxoglutarate analog N-oxalylglycine (2 mM) and competition by additional 2-oxoglutarate (2 mM) (lanes 3 and 4).
Effect of iron chelation, with desferrioxamine (DFO, 100 M) and cobalt (100 M) is shown in lanes 5 and 6.
(C) Hydroxylation of synthetic peptide by purified PHD1. Synthetic HsHIF-1 (B19Pro) peptide was treated with MBP/PHD-1 in the presence
or absence of 2-oxoglutarate. Left panel; HPLC traces. Lower trace shows positions of B19Pro and B19Hyp standards. Right panel; capture
of HsVHL. Appearance of the hydroxylated peptide concords with ability to interact with HsVHL. Note that the reaction did not go to completion.
This was observed in other experiments and most likely represents self-inactivation of the enzyme under in vitro reaction conditions.
trolled hypoxia work station. We first measured the ef- performed using PHD-1 produced in reticulocyte lysate
by IVTT, or purified MBP/PHD-1 obtained by expressionfect of graded hypoxia on the HsHIF modifying activity
of extracts of vhl-defective RCC4 cells that contain a in E. coli. Similar progressive reductions in the activity
of each preparation were observed with graded hypoxiarelatively high level of total HIF-PH activity. A progres-
sive reduction in activity was observed with graded hyp- (Figure 7C, lower panels). Thus, the activity of recombi-
nant PHD-1 from either source parallels that observedoxia (Figure 7C, upper panel). Similar assays were then
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Figure 7. Regulation of HIF-PHs by Oxygen
(A) Representative RNase protection assays showing the effect of hypoxia (1% oxygen, 16 hr) on mRNA levels for PHD1, PHD2, and PHD3
in HeLa cells. Fifty micrograms total RNA was assayed; left hand lane () is a no RNA control.
(B) Effect of 4 hr hypoxia and actinomycin D (1 M final concentration, added 30 min prior to 4 hr hypoxic exposure) on total HIF-PH activity
in HeLa cells. Activity of extracts prepared from the HeLa cells (250 g of protein in 50 l) was measured as the ability to modify purified
Gal/HsHIF-1549-582/VP16 substrate in vitro to promote capture of 35S-labeled HsVHL. Reactions were performed in air.
(C) Representative experiment showing the effect of graded hypoxia on HIF-PH activity in vitro. Activity was measured by HsVHL capture assays
using purified Gal/HsHIF-1549-582/VP16 substrate as above. Reactions were performed in the indicated atmospheric oxygen concentrations in
a hypoxia workstation. Upper panels, activity of cell extracts prepared from RCC4 cells cultured in normoxia; lower left panel, activity of
PHD-1 expressed in reticulocyte lysate IVTT; lower right panel, activity of purified bacterially expressed MBP/PHD-1.
in crude cell extracts, in respect of oxygen-dependent the catalytic site. Kinetic and time-resolved crystallo-
graphic studies of the catalytic mechanism amongmodulation.
members of this class of oxygenase have indicated or-
dered binding of iron (II), 2-oxoglutarate, and prime sub-Discussion
strate (Zhang et al., 2000; Zhou et al., 1998). Binding of
the latter “primes” the enzyme for reversible binding ofRecent work in mammalian cells has demonstrated that
posttranslational modification by prolyl hydroxylation dioxygen, probably by displacing a water molecule from
the iron. Weak binding at the iron center is associatedtargets HIF- to the VHL ubiquitylation complex leading
to rapid proteasomal degradation (Ivan et al., 2001; with a cofactor requirement for iron (II). In keeping with
this, we found that the activity of the recombinant en-Jaakkola et al., 2001). Characterization of the modifying
activity in cell extracts predicted that the relevant en- zyme required iron, and was directly inhibited by cobal-
tous ions, probably by substitution at the iron center.zyme(s) would belong to the 2-oxoglutarate-dependent
oxygenase superfamily—the requirement for dioxygen Moreover, we found that a mutation (PHD1; H358A) that
is predicted to abrogate iron binding, but not otherwiseas cosubstrate suggesting a function in cellular oxygen
sensing. Here, we demonstrate the existence of a ho- alter the three-dimensional structure (Lloyd et al., 1999),
completely ablated enzyme activity. By conducting re-mologous HIF-VHL-prolyl hydroxylase system in C. ele-
gans, and use a genetic approach to identify a novel func- actions in a controlled oxygen environment, we showed
that the activity of the purified enzyme was strikinglytional group of 2-oxoglutarate-dependent oxygenases
that function as HIF-PHs. The critical role of this process sensitive to graded levels of hypoxia in vitro. Though
unknown intracellular oxygen gradients make directin the regulation of HIF is emphasized by analysis of
vhl-1 and egl-9 mutant worms, which show essentially comparison subject to some uncertainty, these findings
mirror the progressive increases in HIF-1 protein andcomplete loss of regulation of CeHIF-1 by oxygen.
Secondary structural analysis predicts that the HIF- DNA binding that are observed when cells are exposed
to graded hypoxia in culture (Jiang et al., 1996).PHs fold to produce a common jelly roll structure that
positions a nonheme-iron coordinating HXD...H motif at Thus, the classical features of HIF induction by hyp-
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oxia, cobaltous ions, and iron chelators can be ex- tions. Interestingly, EGL-9 possesses an N-terminal zinc
plained, at least qualitatively, by the properties of recom- finger domain that we have shown is unnecessary for
binant HIF-PH enzymes. Whether the characteristics of HIF-PH activity and may have other functions.
these enzymes can explain other described responses Given the lethal effects of HsVHL and HsHIF-1 dis-
of the HIF system is less clear. The hydroxylation section ruption on mammalian development, it is of interest that
of the catalytic mechanism is believed to proceed by a vhl-1 and egl-9 worms are viable. Hif-1 mutant worms
radical rebound mechanism (Lloyd et al., 1999; Wu et are also viable under laboratory conditions, though de-
al., 1999), and may be relevant to different reported fective in their ability to withstand hypoxia (Jiang et al.,
effects of reactive oxygen species on HIF regulation 2001). The availability of mutant worms at each level in
(for review, see Semenza, 1999; Zhu and Bunn, 2001). the pathway should help define the overlapping and
Furthermore, the ability of nitric oxide (NO) to bind to nonoverlapping functions of CeHIF-1, the tumor sup-
enzyme–iron (II)–2-oxoglutarate complexes of this class pressor homolog CeVHL-1, and the prolyl hydroxylase
(Z.H. Zhang, C.J.S., and coworkers, unpublished results) EGL-9.
may be relevant to the reported effects of NO donors In mammals, the HIF system regulates not only cellular
on HIF regulation (Huang et al., 1999; Palmer et al., 2000). responses to oxygen, but also a range of systemic func-
The availability of recombinant HIF-PHs will now permit tions such as regulation of angiogenesis, erythropoiesis,
direct testing of these possibilities, and an important and vasomotor control. These complex requirements
challenge will be to determine the extent to which the have argued against the concept of a single oxygen
complex demands of physiological oxygen homeostasis sensor. However, the existence in mammalian cells of
are met by the biochemical properties of these enzymes. (at least) three isoforms of HIF-PH, and (at least) two
Identification of the HIF system in nematode worms isoforms of HIF- each with more than one site of prolyl
that obtain oxygen by diffusion reveals that the system hydroxylation (Masson et al., 2001), provides the poten-
must have evolved before the development of complex tial for differently tuned physiological responses to oxy-
systemic oxygen delivery systems, presumably to regu- gen availability. Furthermore, previous studies of rat SM-
late responses to oxygen availability at the cellular level. 20 have demonstrated regulation at the mRNA level by
In keeping with these simpler requirements, the HIF sys- stimuli that include p53 activation, and exposure to a
tem appears to be less complex in C. elegans than in variety of growth factors (Madden et al., 1996; Wax et
mammals. Complete loss of CeHIF-1 regulation in egl-9 al., 1994). Since these oxygenases are nonequilibrium
mutants suggests that there may be only one HIF-PH enzymes, changes in the level of enzyme will affect the
in worms, and we have so far defined only one site of potential rate of HIF hydroxylation, as was suggested
hydroxylation in a single HIF- homolog. Furthermore, by the effects of hypoxia on mRNA levels and total HIF-
in the survey of mutant worms, we were unable to dem- PH activity in HeLa cells. Such additional controls over
onstrate major interactions with oxygen radical metabo- HIF activity may provide feedback, and may also influ-
lism such as have been proposed in mammalian cells. ence the interactions between oxygen availability and
Definition of this mechanism of proteolytic targeting nonhypoxic stimulation of HIF by growth factors and
by prolyl hydroxylation and the frequent occurrence of cytokines (reviewed in Maxwell et al., 2001).
prolyl residues in short-lived proteins raises the question Finally, the identification of the HIF-PHs also raises
as to whether these enzymes have a broader role in therapeutic possibilities. Inhibitors of HIF-PHs might be
proteolytic targeting or signaling. Though we found that used to activate HIF and enhance angiogenesis in isch-
C. elegans and mammalian enzymes were not function- emic/hypoxic disease. Application of the 2-oxoglutarate
ally interchangeable (data not shown), implying some analog dimethyloxalylglycine to tissue culture cells
differences in substrate selectivity, the existence of a strongly induces HIF target genes (D.R.M., unpublished
conserved LXXLAP motif at the hydroxylation sites may observations). Though this compound is not specific for
help define other targets. In this respect, it is of interest
the HIF-PHs and inhibits other 2-oxoglutarate dioxygen-
that C. elegans egl-9 and the mammalian HIF-PH, SM-
ases, structural and mechanistic studies of the defined
20 have been identified previously in different contexts.
enzymes may now permit design of more specific inhibi-The SM-20 gene was first identified as a transcript in-
tors for therapeutic development.duced by platelet-derived growth factor stimulation in
rat smooth muscle cells (Wax et al., 1994), and subse-
quently, as a gene that is functionally involved in apopto- Experimental Procedures
sis and growth regulation (Lipscomb et al., 2001; Mad-
C. elegans Culture, Strains, and Extract Preparationden et al., 1996). Interestingly, these studies have shown
Worms were cultured using standard methods. Exposure to hypoxiathat SM-20 immunoreactivity is localized in part to the
was in bell jars gassed with humidified air or certified nitrogen/
mitochondrion (Lipscomb et al., 2001). In C. elegans, oxygen mixes (British Oxygen Company). Exposure to 2,2 dipyridyl
egl-9 was first identified as a gene responsible for an (200 M), or dimethyloxalylglycine (1 mM) was performed in liquid
egg-laying defect (Trent et al., 1983). Subsequently, fur- medium. Wild-type worms were Bristol strain (N2). Mutant strains
ther egl-9 mutants were isolated in a screen for worms were obtained from the Caenorhabditis Genetics Centre or the origi-
nators, and are as indicated in Supplemental Table S1 (availableresistant to a Pseudomonas aeruginosa toxin (Darby et
online at http://www.cell.com/cgi/content/full/107/1/43/DC1). A de-al., 1999). Whether these functions relate to effects on
letion mutant in the vhl-1 gene (ok161) was generated using trimeth-the HIF system or other prolyl hydroxylation targets is
ylpsoralen. The vhl-1 strain CB5603 was constructed by backcross-
unclear. However, despite similar upregulation of the ing ok161 two times against wild-type (N2), then constructing a triple
HIF system in vhl-1 and egl-9 mutant worms, the vhl-1 mutant with markers on either side of vhl-1 (genotype: dpy-6 (e2562)
worms do not manifest an egg laying defective pheno- vhl-1 (ok161) unc-9 (e101)), and then removing these markers by
further crosses against N2.type, suggesting the existence of nonoverlapping func-
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Worm extracts were prepared by homogenization (Ultraturax T20, Interaction Assays
Assays for interaction between recombinant VHL and HIF polypep-IKA Labortechnik) in 4 volumes extraction buffer (150 mM NaCl, 1
mM EDTA, 50 mM Tris [pH 7.5], 1% NP-40, and 1% sodium deoxy- tides conformed to the following experimental design: Recombinant
VHL and HIF polypeptides were produced separately in vitro. Thecholate) for immunoblotting, or in 2 volumes of hypotonic extraction
buffer, HEB (20 mM Tris [pH 7.5], 5 mM KCl, 1.5 mM MgCl2, and HIF polypeptide was then preincubated with extract or a recombi-
nant enzyme as indicated, then mixed with VHL and incubated in1 mM DTT) for modification reactions. Forty micrograms of extract
was used for immunoblots and 150 g used in modification reac- EBC buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 0.5% v/v Igepal,
and 0.5 mM EDTA) at 4C for 1 hr, before immunoprecipitation withtions.
anti-HA antibodies (for HA tagged VHL) or anti-Gal antibodies (for
GalHIF fusions) and analysis by PAGE.Mammalian Cells and Extract Preparation
Preincubation of CeHIF-1 with worm extract or recombinantHeLa and RCC4 cells were cultured in DMEM. Cell extracts were
EGL-9 was for 30 min at 25C. Preincubation of HsHIF- polypep-prepared in HEB.
tides with cell extract or recombinant enzymes was at 37C for 10–30
min unless otherwise stated. For assays of recombinant enzymes,Antibodies
2-oxoglutarate (2 mM), iron (100 M), and ascorbate (2 mM) wereAntisera to CeHIF-1 and CeVHL-1 were produced in rabbits immu-
added to the reaction buffer unless otherwise indicated. Reactionsnized with either a glutathione-S-transferase fusion protein express-
performed in hypoxia were in the stated atmospheric oxygen con-ing amino acids 360–498 of CeHIF-1, or a maltose binding protein
centration (balance nitrogen), obtained using a controlled environ-fusion linked to full-length (I-174) CeVHL-1. Mouse anti-HA antibody
ment Invivo2 400 hypoxia workstation (Ruskinn Technologies), andwas 12CA5 (Roche), and mouse anti-Gal antibody was RK5C1 (Santa
buffers preequilibrated with the appropriate atmosphere. ReactionsCruz).
(50 l) were performed in open Eppendorf tubes with mixing and
stopped by the addition of 20 volumes desferrioxamine (100 M).RNA Analysis
For peptide blocking experiments, CeVHL-1 was preincubatedDetails of riboprobe templates are provided in Supplemental Table
with peptides (1 M final) for 15 min before addition to the inter-S2 (available online at http://www.cell.com/cgi/content/full/107/1/
action.43/DC1). RNA was prepared from a mixed population of worms using
For VHL capture assays using synthetic biotinylated HsHIF1-Tri-Reagent (Sigma), or from HeLa cells using RNAzolB (Biogenesis).
peptides, peptide was preincubated as indicated for 30 min at 37C,Thirty micrograms was used for each assay.
then bound to strepavidin beads, washed, mixed with recombinant
HsVHL or extract, recaptured using beads, and bound HsVHL ana-
Plasmids
lyzed by PAGE.
C. elegans cDNAs
For HsHIF-1 capture assays using 786-0/VHL cell extract,
The C. elegans hif-1 cDNA was assembled from 4 overlapping cDNA
HsHIF-1 polypeptides were produced by IVTT, preincubated with
clones, yk510h7, yk4a2, yk383g1, and yk272d11 (Y. Kohara, National
enzyme, then interacted with cell extract under conditions (10 mM
Institute of Genetics, Japan), and inserted into pcDNA1AMP (In-
Tris [pH 7.5], 0.25 M NaCl, and 0.5% NP40, at 4C) that do not permit
vitrogen). The C. elegans vhl-1 cDNA and the cDNA encoding the
modification of HsHIF1- (Masson et al., 2001), then immunoprecipi-
predicted ORF of T20B3.7 were obtained by RT-PCR of worm RNA
tated with anti-HA, and analyzed by PAGE.
and inserted into pcDNA3 (with linkers that encoded an N-terminal
HA tag), and pSP72 (Promega), respectively. The egl-9 cDNA was
HPLC Analysessubcloned into pcDNA1 from yk130h5 (Y. Kohara). Phy-1 (Dpy-18)
Hydroxylation of the HsHIF-1 peptide B19Pro (residues 556–574)and phy-2 cDNAs in pCR-Script were provided by Anthony Page,
was analyzed by reverse phase HPLC using a C-18 (octadecylsilane)University of Glasgow, Scotland, UK. Gal/CeHIF-1 fusion proteins
column and water/acetonitrile 0.1% TFA as the mobile phase. Stan-were generated by PCR and inserted into pcDNA3Gal (O’Rourke et
dards were unmodified B19Pro and a synthetic peptide (B19Hyp)al., 1999).
bearing a hydroxyproline substitution at Pro564.For insect cell expression, sequences encoding Gal/CeHIF-1(289-
For analysis of hydroxyproline, peptides or proteins were subject790) and EGL-9 (1-723) were subcloned into pFastBac1 (Gibco BRL).
to acid hydrolysis, derivatization with phenylisothiocyanate andFor bacterial expression, sequences encoding Gal/CeHIF-1(590-
HPLC using standard methods. Decarboxylation assays were per-790) and EGL-9 (359-723) were subcloned into pET-28a (Novagen),
formed using 1-[14C]-2-oxoglutarate, purified polypeptide substratesand pMAL-p2X (NEB), respectively.
at approximately 25 M, and a purified MBP/PHD1 fusion as de-Mammalian cDNAs
scribed (Mukherji et al., 2001).The cDNAs encoding the human polypeptides designated PHD1,
PHD2, and PHD3 were obtained by PCR amplification and/or restric-
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Caines, I.C. Clifton, J. Elkins, S. Kim, L.G. Nicholls, A.C. Willis, and(Lipscomb et al., 2001) (provided by R. Freeman, University of Roch-
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Kaelin, Jr., J. Kimble, Y. Kohara, C. Manoil, and A. Page for provisionlocyte lysate IVTT; sequences encoding amino acids 60–355 were
of reagents.subcloned into pTYB11 (NEB) for expression in E. coli.
For bacterial expression, human HIF-1 sequences encoding
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